Optimal Large-Bore Femoral Access, Indwelling Device Management, and Vascular Closure for Percutaneous Mechanical Circulatory Support

Y Sandoval, MB Basir, A Lemor, H Lichaa… - American Journal of …, 2023 - ajconline.org
TaggedAPTARAPThe number of large-bore transfemoral artery access procedures has
increased substantially in recent years, primarily because of the increasing use of larger …

Microaxial left ventricular assist device in cardiogenic shock: a systematic review and meta-analysis

SR Tan, CJW Low, WL Ng, RR Ling, CS Tan, SL Lim… - Life, 2022 - mdpi.com
Microaxial left ventricular assist devices (LVAD) are increasingly used to support patients
with cardiogenic shock; however, outcome results are limited to single-center studies …

Impella versus non-Impella for nonemergent high-risk percutaneous coronary intervention

P Reddy, I Merdler, C Zhang, M Cellamare… - The American Journal of …, 2024 - Elsevier
The benefit of mechanical circulatory support with Impella (Abiomed, Inc., Danvers,
Massachusetts) for high-risk percutaneous coronary intervention (HR-PCI) is uncertain …

High-risk percutaneous coronary intervention with or without mechanical circulatory support: Will Impella show superiority in the PROTECT IV randomized trial?

KR Chitturi, C Zhang, W Abusnina, V Sawant… - Cardiovascular …, 2024 - Elsevier
Background PROTECT IV is a current enrolling randomized controlled trial evaluating high-
risk percutaneous coronary intervention (HR-PCI) with prophylactic Impella versus no …

Best practices for vascular arterial access and closure: a contemporary guide for the cardiac catheterization laboratory

M Eltelbany, M Fabbri, WB Batchelor, L Cilia… - Frontiers in …, 2024 - frontiersin.org
More than 1 million transcatheter-based cardiovascular procedures across the spectrum of
interventional cardiology are performed annually in the United States. With the expanded …

Impella versus Non-Impella for Non-emergent High-Risk Percutaneous Coronary Intervention: Impella vs. Non-Impella for HR-PCI

P Reddy, I Merdler, C Zhang, M Cellamare… - The American Journal of …, 2025 - Elsevier
Background The benefit of mechanical circulatory support (MCS) with Impella (Abiomed, Inc,
Danvers, MA) for patients undergoing non-emergent, high-risk percutaneous coronary …

[HTML][HTML] Suture-mediated intermediate and terminal closure when using the aortix percutaneous mechanical circulatory support device

MA Khuddus, MB Basir, A Palmer, A Edidin - Journal of the Society for …, 2023 - Elsevier
Abstract Background The Aortix percutaneous mechanical circulatory support (pMCS) 18F
micromechanical axial impeller–driven pump is percutaneously placed and retrieved from …

Outcome of Patients Managed by Percutaneous Left Ventricular Assist Device Implantation During On-Hours and Off-Hours

J Haschemi, D Oehler, JM Haurand, F Voss… - ASAIO …, 2024 - journals.lww.com
Percutaneous left ventricular assist devices (pVADs) may be used in patients with
cardiogenic shock (CS) to stabilize hemodynamics and maintain sufficient end-organ …

SAICR‐CTO: Single Access Impella‐Guided Complete Revascularization in Chronic Total Occlusion—A Novel Approach to High‐Risk PCI

V Sharma, A Arokiadoss, A Bhardwaj… - Catheterization and …, 2024 - Wiley Online Library
The Impella is a ventricular assist device (VAD) that provides circulatory assistance to
patients with impaired heart function during percutaneous coronary intervention (PCI). It …

Preclose cinching “C-stitch” to aid hemostasis after Impella insertion

D Saleem, SS Sethi, SA Parikh, MV Madhavan… - Journal of the Society for …, 2022 - jscai.org
After approximately 48 hours, the patient was deemed stable for Impella removal. The groin
was sterilely prepared, and the stopcock was removed to access the ProGlide sutures …